Answers are grounded in this paper and cite their sources.
Prologue: Over the course of this century academic health centers (AHCs) have emerged as key players in the complex process of developing technology and moving it from the laboratory to the medical marketplace. Recent trends toward price competition and increased regulation in hospital reimbursement rates, however, threaten to eliminate traditional funding sources for research and development (R&D) in these institutions. Some reformers have proposed explicit federal funding that would substitute for AHCs' loss of revenue from other sources. In this paper Gerard Anderson and colleagues trace the evolution of AHCs and highlight their role in medical R&D. They warn that the imminent shift in funding sources could have serious consequences for the future course of medical innovation. The authors stress the importance of having a well-defined set of priorities and a clear understanding of the factors that foster innovation in AHCs. Anderson, a well-regarded expert in health care finance with a doctorate in public policy analysis from the University of Pennsylvania, is director of the Center for Hospital Finance and Management at The Johns Hopkins University in Baltimore. Earl Steinberg, a nationally recognized expert in technology assessment, is professor of medicine and health policy and management at Hopkins and directs the Hopkins Program for Medical Technology and Practice Assessment. He holds a medical degree from Harvard Medical School and a master of public policy degree from Harvard's Kennedy School. Robert Heyssel, a physician, is president emeritus of The Johns Hopkins Health System and The Johns Hopkins Hospital, having stepped down in 1992 after nearly twenty years at the helm. Heyssel received his medical degree from St. Louis University. He is a member of the National Academy of Sciences' Institute of Medicine and has had a long, distinguished career in medical practice and administration in both public and private sectors. Abstract: Academic health centers (AHCs) now play major roles in the development, adoption, and evaluation of medical technologies; the provision of advice to other entities involved in medical innovation; and the education of current and future practitioners. However, recent and potential health care reform initiatives could make it increasingly difficult for AHCs to continue to play their historical roles in medical innovation. Policymakers are examining specific options that would explicitly cover the cost of some of these services but could take away some of the autonomy AHCs have enjoyed and could change the role of AHCs in technological innovation.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: